Author Interviews, Dengue, Lancet, OBGYNE / 07.03.2016
Dengue During Pregnancy Linked to Adverse Fetal Outcomes
MedicalResearch.com Interview with:
Mrs Enny S Paixão
London School of Hygiene & Tropical Medicine
London UK
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Dengue is a vector borne disease endemic in more than 100 countries (mainly in South America and southeast Asia) and is spreading to new areas, with outbreaks of increasing magnitude and severity. It is estimated that each year, 390 million people are infected with dengue and 96 million develop clinical symptoms. Despite of the importance of this disease, the effects of disease during pregnancy on fetal outcomes remain unclear. Using the published scientific literature, we investigated the risk of stillbirth, miscarriage, preterm birth, and low birth weight for women who had dengue infection during pregnancy.
This study showed some evidence that dengue infection alone, in the absence of clinical symptoms, does not affect the outcome of pregnancy, but also that clinical dengue during pregnancy seems to increase the frequency of stillbirth, prematurity, and low birthweight.







Dr. Cuilin Zhang[/caption]
MedicalResearch.com Interview with:
Cuilin Zhang MD, PhD
Senior Investigator, Epidemiology Branch
Division of Intramural Population Health Research
NICHD/National Institutes of Health
Rockville, MD 20852
Medical Research: What is the background for this study? What are the main findings?
Dr. Zhang: Potatoes are the third most commonly consumed food crop in the world. In the United States, about 35% of women of reproductive age consume potatoes daily, accounting for 8% of daily total energy intake. Gestational diabetes mellitus (GDM) is a common complication of pregnancy characterized by glucose intolerance with onset or first recognition during pregnancy.
Dr. Rowan[/caption]
MedicalResearch.com Interview with:
Dr. Janet Rowan
Obstetric Physician
National Women's Health,
Auckland
Medical Research: What is the background for this study?
Dr. Rowan: Clinicians are interested in screening during early pregnancy to identify women with previously unrecognised diabetes, as these women have increased risks of adverse pregnancy outcomes. HbA1c is a simple and reproducible measure of glucose elevations, but its usefulness as an early pregnancy screening test is not clear. The aim of this study was to examine whether pregnant women with an HbA1c of 41-49mmol/mol (5.9-6.6%) are a high risk subgroup and whether treating these women from early pregnancy improves outcomes compared with identifying them during routine screening for gestational diabetes (GDM) from 24 weeks’ gestation.
This observational study compared women referred to the diabetes clinic <24 weeks’ who had an early pregnancy
Prof. Cnattingius[/caption]
MedicalResearch.com Interview with:
Professor Sven Cnattingius
Professor in reproductive epidemiology
Clinical Epidemiology Unit, Department of Medicine
Karolinska University Hospital
Karolinska Institutet, Stockholm, Sweden
Medical Research: What is the background for this study?
Prof. Cnattingius: Maternal overweight and obesity are associated with increased risks of stillbirth and infant mortality.
Weight gain between pregnancies increases risks of other obesity-related complications, including preeclampsia, gestational diabetes, and preterm birth. Weight gain appear to increase these risks especially in women who start off with normal weight.
As these complications increases risks of stillbirth and infant mortality, we wanted to study the associations between weight change between successive pregnancies and risks of stillbirth and infant mortality (deaths during the first year of life).
Medical Research: What are the main findings?
Prof. Cnattingius: The main findings include:
Dr. Klebanoff[/caption]
MedicalResearch.com Interview with:
Mark A. Klebanoff, MD
Center for Perinatal Research
The Research Institute
Nationwide Children's Hospital
Medical Research: What is the background for this study? What are the main findings?
Dr. Klebanoff: Caffeine is among the substances most commonly consumed by pregnant women. There are numerous sources of caffeine in the diet—regular (non-decaf) coffee, regular tea, many soft drinks,
Dr. Braun[/caption]
MedicalResearch.com Interview with:
Joseph M. Braun PhD
Assistant Professor
Department of Epidemiology in the Program in Public Health
Brown University
Medical Research: What is the background for this study?
Dr. Braun: Perfluoroalkyl substances are a class of chemicals used to produce stain/water repellent textiles, fire fighting foams, and non-stick coatings. Virtually all people in the US have measurable levels of several different perfluoroalkyl substances in their blood. There is concern that early life exposure to these chemicals can increase the risk of obesity by reducing fetal growth or promoting adipogenesis.
What are the main findings?
Dr. Braun: Pregnant women in our study had perfluorooctanoic acid (PFOA) concentrations in their blood that were over 2-fold higher than pregnant women in the United States (median: 5.3 vs. 2.3 ng/mL) during the same time period (2003-2006).
Children born to women with higher serum PFOA concentrations during pregnancy had a higher body mass index, greater waist circumference, and more body fat at 8 years of age compared to children born to women with lower serum PFOA concentrations











